日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

230. A Novel SARS-CoV-2 mRNA Virus-Like Particle Vaccine is Highly Potent and Well Tolerated in Adults in a Phase I Randomized Clinical Trial

230. 一项I期随机临床试验表明，一种新型SARS-CoV-2 mRNA病毒样颗粒疫苗在成人中具有高效性和良好的耐受性。

期刊:ACS Omega
影响因子:4.3
doi:10.1021/acsomega.5c10950
Feng, Yutong; Sun, Hui; Liu, Xinyu; Wu, Huiping; Chen, Gaoyuan; Gao, Afang; Wang, Shijie; Zhou, Jiahui; Yu, Bin; Oyedele, Tope; Park, Rachel; Morales, Kelly; Jain, Manish; Sher, Lawrence; Vutikullird, Apinya; Klein, Thomas; Isaacs, Abby; Shoemaker, Kathryn; Stanley, Ann Marie; Lee, Joseph; Handelsman, Cindy; Berman, Stacey Cromer; Chang, Lee-Jah
微生物学
SARS-CoV-2
发表日期：2026
文献求助 收藏

A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females

一项针对健康女性的 Erenumab 与复方口服避孕药的多中心、开放标签、药代动力学药物相互作用研究

期刊:CNS Drugs
影响因子:7.4
doi:10.1007/s40263-019-00626-2
Xu, Yang; Gabriel, Kristin; Wang, Yi; Zhou, Yanchen; Eisele, Osaro; Vutikullird, Apinya; Mikol, Daniel D; Lee, Edward
发表日期：2019
文献求助 收藏

Correction to: A Multi‑Center, Open‑Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females

更正：一项针对健康女性的 Erenumab 与复方口服避孕药的多中心、开放标签、药代动力学药物相互作用研究

期刊:CNS Drugs
影响因子:7.4
doi:10.1007/s40263-019-00638-y
Xu, Yang; Gabriel, Kristin; Wang, Yi; Zhou, Yanchen; Eisele, Osaro; Vutikullird, Apinya; Mikol, Daniel D; Lee, Edward
发表日期：2019
文献求助 收藏

A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumab

一项曲妥珠单抗生物类似药MYL-1401O与欧盟曲妥珠单抗和美国曲妥珠单抗的药代动力学I期生物等效性研究

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.13689
Waller, Cornelius F; Vutikullird, Apinya; Lawrence, Tracey E; Shaw, Andrew; Liu, Mark Shiyao; Baczkowski, Mark; Sharma, Rajiv; Barve, Abhijit; Goyal, Parag; Donnelly, Charles; Sengupta, Nilanjan; Pennella, Eduardo J
发表日期：2018
文献求助 收藏

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

0.77%盐酸奥洛他定滴眼液在无症状健康受试者中的药代动力学和安全性：来自两项独立临床研究的数据

期刊:
影响因子:
doi:10.2147/OPTH.S126690
Meier, Edward; Narvekar, Abhijit; Iyer, Ganesh R; DuBiner, Harvey B; Vutikullird, Apinya; Wirta, David; Sall, Kenneth
发表日期：2017
文献求助 收藏

Randomized, placebo-controlled, single-ascending-dose study of BMS-791325, a hepatitis C virus (HCV) NS5B polymerase inhibitor, in HCV genotype 1 infection

一项随机、安慰剂对照、单次递增剂量研究，评估丙型肝炎病毒 (HCV) NS5B 聚合酶抑制剂 BMS-791325 在 HCV 基因 1 型感染中的疗效。

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02579-13
Sims, Karen D; Lemm, Julie; Eley, Timothy; Liu, Menping; Berglind, Anna; Sherman, Diane; Lawitz, Eric; Vutikullird, Apinya B; Tebas, Pablo; Gao, Min; Pasquinelli, Claudio; Grasela, Dennis M
炎症/感染
肝炎
多发性硬化症
微生物学
发表日期：2014
文献求助 收藏

Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies

抗埃博拉病毒和马尔堡病毒的磷酰二胺吗啉寡聚物的安全性和药代动力学特征：两项单次递增剂量研究的结果

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.03442-14
Heald, Alison E; Iversen, Patrick L; Saoud, Jay B; Sazani, Peter; Charleston, Jay S; Axtelle, Tim; Wong, Michael; Smith, William B; Vutikullird, Apinya; Kaye, Edward
微生物学
发表日期：2014
文献求助 收藏